Synlogic stock
To take any of these actions regarding your Synlogic stock, please contact the American Stock Transfer & Trust Company, LLC, Synlogic’s transfer agent. Some of these requests may involve a fee. American Stock Transfer & Trust Company (800) 937-5449 (Toll-free) (718) 921-8124 (International)Synlogic Stock Price, News & Analysis (NASDAQ:SYBX) $2.39 +0.30 (+14.35%) (As of 11/29/2023 ET) Compare Today's Range $2.00 $2.40 50-Day Range …
Did you know?
Synlogic, Inc. Common Stock (SYBX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 7.69% and 73.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?Synlogic Announces Reverse Stock Split. CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non ...
What is the target price for Synlogic (SYBX) stock? A. The latest price target for Synlogic ( NASDAQ: SYBX) was reported by Chardan Capital on Friday, August 11, 2023. The analyst firm set a price ...Upcoming Industry and Banking Conferences. Synlogic will participate in the banking and industry conferences listed below in early 2022. Recorded presentations will be available at https://investor.synlogictx.com.. H.C. Wainwright BIOCONNECT Virtual Conference. Synlogic will present a corporate update at the H.C. Wainwright …Synlogic (SYBX) Presents At Jefferies 2017 London Healthcare Conference - Slideshow. SA Transcripts Fri, Nov. 17, 2017 1 Comment. All earnings call transcripts on Synlogic, Inc. (SYBX) stock. Read ...Synlogic, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in advancing therapeutics based on synthetic biology. Its pipeline includes its program in phenylketonuria (PKU), and additional drug candidates designed to treat homocystinuria (HCU), enteric hyperoxaluria and gout.Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 19.23% and 80.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
SYBX | Overview of Synlogic Inc stock by Investoreight. View stock price, financials, news, earnings, and performance of Synlogic Inc - Investoreight.CAMBRIDGE, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today reported financial results for the ...CAMBRIDGE, Mass., March 24, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that SYNB8802 has achieved proof of mechanism in a Dietary Hyperoxaluria study in which healthy volunteers on a high oxalate and low ……
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Find the latest Synlogic, Inc. (SYBX) stock discussion in Y. Possible cause: What is Synlogic's consensus rating and price target? Ac...
TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comOn average, Wall Street analysts predict. that Synlogic's share price could reach $82.50 by Aug 11, 2024. The average Synlogic stock price prediction forecasts a potential upside of 4,025% from the current SYBX share price of $2.00.
Synlogic’s pipeline is fueled by its Synthetic Biotic platform, which applies precision engineering to well-characterized probiotics. This creates GI-restricted, oral medicines designed to consume or modify disease-specific metabolites – an approach well suited for diseases such as PKU and HCU, both inborn errors of metabolism, as well as others in …SYBX Stock Performance Soars with 1,939.98% Increase: Analysts Predict Strong Growth for Synlogic Inc. SYBX stock had a significant performance on September 27, 2023. The 12-month price forecasts from three analysts for Synlogic Inc had a median target of $5.00, with a high estimate of $6.00 and a low estimate of $4.00.
chase refinance mortgage rates Figure 5: Synlogic Stock Chart (source: finviz) Thus, Synlogic looks like a good value at current levels, although, obviously, still a high-risk investment due to the early stages of its assets. rob roy traderbilf. Find the latest Synlogic, Inc. (SYBX) stock quote, history, news and other vital information to help you with your stock trading and investing. air transat credit card SYBX | Overview of Synlogic Inc stock by Investoreight. View stock price, financials, news, earnings, and performance of Synlogic Inc - Investoreight.2.46. +0.16. +6.96%. Get Synlogic Inc (SYBX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. option trading ideasnios stockaverage cost of a hospital stay per day Synlogic (NASDAQ:SYBX) is another biotech company, this time promising to treat diseases with high unmet need. It is a synthetic biology company focused on harnessing the power of artificial ... openai publicly traded First Quarter 2023 Financial Results. As of March 31, 2023, Synlogic had cash, cash equivalents and short-term investments of $57.4 million. Revenue was $0.2 million for each of the three months ...Nov 9, 2023 · Synlogic is a biotechnology company that designs Synthetic Biotics, living probiotics that treat diseases with Synthetic Biotic pipeline. The web page provides stock quote, chart, news releases, events, and corporate documents of Synlogic, as well as investor resources and contact information. 2023 bmw 8 series coupeoil refineries in usbils stock Synlogic saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 90,800 shares, a decline of 41.7% from the previous total of 155,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment.